loader from loading.io

Alicia Danforth PhD - ICPR 2020: Ethical Challenges in Psychedelic Medicine

Psychedelics Today

Release Date: 03/03/2020

Dylan Beynon - Mindbloom: The Next Chapter in Mental Health and Wellbeing show art Dylan Beynon - Mindbloom: The Next Chapter in Mental Health and Wellbeing

Psychedelics Today

In this episode, Kyle sits down with Dylan Beynon, founder of Mindbloom, NYC based mental health and wellbeing platform. In the show they talk about how Mindbloom differs from other centers, paving the way for accessibility and affordability. 3 Key Points: Mindbloom is a next-generation mental health platform, catered to accessibility and affordability. They use ketamine tablets, different from lozenges and any other method. The tablets are held in the mouth and then spit out to avoid entering the liver, causing a sedation-like experience. Mindbloom differentiates themselves from other...

info_outline
Dr. Ryan Westrum - The Psychedelics Integration Handbook show art Dr. Ryan Westrum - The Psychedelics Integration Handbook

Psychedelics Today

In this episode, Kyle sits down with Dr. Ryan Westrum, Psychedelic Integration Therapist. In the show, they talk about topics and teachings from Ryan’s book, The Psychedelic Integration Handbook. 3 Key Points: The Psychedelics Integration Handbook is designed to bring psychedelic experiences into the flow of your life and maximize their potential for helping you create the life you want to live. There is an important part in distinguishing integration from aftercare. Aftercare can look as simple as taking care of your body, getting good rest, eating well. You can't integrate without taking...

info_outline
Jessica DiRuzza - Understanding the Psychedelic Experience with Astrology show art Jessica DiRuzza - Understanding the Psychedelic Experience with Astrology

Psychedelics Today

In this episode, Kyle interviews Jessica DiRuzza, Psychotherapist, Astrologer and Teacher. In the show they talk about how astrology can be used as a tool and framework for navigating and understanding psychedelic experiences. 3 Key Points: Astrology can be used as an integrative tool for psychedelic and other exceptional experiences. The planets are emitting some type of force that are letting us behave a certain way. Astrology is the one thing we have agreed upon across millennia and era. A Saturn Return transit can be a difficult but transformative time in one's life. This transit happens...

info_outline
Rob Heffernan - Psychedelic Liberty Summit: Religion and Plant Medicines show art Rob Heffernan - Psychedelic Liberty Summit: Religion and Plant Medicines

Psychedelics Today

In this episode, Kyle sits down with Rob Heffernan, an independent researcher and activist. In the show, they talk about churches, Ayahuasca, accessibility and the by the Chacruna Institute for Psychedelic Plant Medicines. Rob is also part of .  The Council for the Protection of Sacred plants is "an initiative of the Chacruna Institute for Psychedelic Plant Medicines that endeavors to advocate for the legality of sacred plant medicines among indigenous peoples and non-indigenous communities, encourage legal harm reduction practices that protect those who use them, educate about...

info_outline
Alicia Danforth PhD - ICPR 2020: Ethical Challenges in Psychedelic Medicine show art Alicia Danforth PhD - ICPR 2020: Ethical Challenges in Psychedelic Medicine

Psychedelics Today

In this episode, Joe interviews Clinical Psychologist, Alicia Danforth. In the show, they cover topics including how to get involved in the space, consent, research, MDMA, Autism and more. 3 Key Points: Alicia Danforth is a Clinical Psychologist who will be having a talk on Ethical Challenges in Psychedelic Medicine at the ICPR Conference in the Netherlands, April 2020. There is a possibility for MDMA to have a non-responder effect. No one has done research dedicated to why some people don't react at all to MDMA. Psychedelic science is very hard to talk about. We have the language of science...

info_outline
Mike Margolies - Psychedelic Seminars: the Benefits, Risks, and Complexities of Psychedelics show art Mike Margolies - Psychedelic Seminars: the Benefits, Risks, and Complexities of Psychedelics

Psychedelics Today

In this episode, Kyle and Joe interview Mike Margolies of Psychedelic Seminars. In the show, they cover topics including guests and conversations from the Psychedelic Seminars, the decriminalization of all drugs, and the importance of allowing psychedelic use to be a part of training therapists for psychedelic therapy. 3 Key Points: Psychedelic Seminars is an educational conversation series deepening awareness of the benefits, risks, and complexities of psychedelics. There are large topics of decriminalizing psilocybin or the movements for ‘decriminalize nature’, but the conversation on...

info_outline
Elizabeth Nielson and Ingmar Gorman - The Importance of Psychedelic Integration Training for Therapists show art Elizabeth Nielson and Ingmar Gorman - The Importance of Psychedelic Integration Training for Therapists

Psychedelics Today

In this Episode, Kyle sits down with Elizabeth Nielson and Ingmar Gorman, Co-founders of Fluence, Training in Psychedelic Integration. They are both therapists on the MAPS clinical trial for MDMA Assisted Psychotherapy for PTSD. 3 Key Points: Elizabeth and Ingmar are co-founders of Fluence, an online Psychedelic Integration Training program. If psychedelic treatments become available more widely, the fear is that therapists won't be as educated on how to handle their patient interactions based on the behavior of each psychedelic. Psychedelic Integration Therapy Training is so important. There...

info_outline
Jon S. - NYU’s Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence show art Jon S. - NYU’s Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence

Psychedelics Today

In this episode, Joe interviews Jon S. on his experience in the psilocybin-assisted trials for alcohol dependency at NYU. In the show, they dive into Jon’s background and how psilocybin assisted therapy helped him out of his alcohol dependence and into a new life. 3 Key Points: Jon participated in the NYU Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence. The study was double-blind. In each session, he didn't know if he was going to receive psilocybin or Benadryl.  The sessions helped him so much with this dependence on alcohol, he believes he is a better...

info_outline
Joost Breeksema - The Interdisciplinary Conference on Psychedelic Research show art Joost Breeksema - The Interdisciplinary Conference on Psychedelic Research

Psychedelics Today

In this episode, Joe interviews Joost Breeksema from the Netherlands to talk about the Interdisciplinary Conference on Psychedelic Research. In the show they cover topics on ICPR 2020, and the importance of accessibility. 3 Key Points: The Interdisciplinary Conference on Psychedelic Research takes place April 24-26, 2020 in the Netherlands. It's important to acknowledge the indigenous, ethical, and political dimensions to psychedelic use at conferences. Although this conference will be catered toward mainstream science and research, personal experiences and stories are important too. ...

info_outline
Hallie Rose and Kyle Buller - Soltara Healing Center and Kyle’s Experience with the Plant Medicine show art Hallie Rose and Kyle Buller - Soltara Healing Center and Kyle’s Experience with the Plant Medicine

Psychedelics Today

In this episode, Kyle invites a guest interviewer, Hallie Rose of the Thought Room Podcast, to interview him on his recent experience at Soltara. In the show, they talk about Soltara, Kyle’s experience with the plant medicine, and important topics like privilege.  3 Key Points: Eastern attendees have a different integration need than Western attendees. In the West, attendees come back to more hustle and bustle, more time is needed for integration. Soltara does a really good job at providing that time for integration.   With Psilocybin and other psychedelics, there is this one...

info_outline
 
More Episodes

In this episode, Joe interviews Clinical Psychologist, Alicia Danforth. In the show, they cover topics including how to get involved in the space, consent, research, MDMA, Autism and more.

3 Key Points:

  1. Alicia Danforth is a Clinical Psychologist who will be having a talk on Ethical Challenges in Psychedelic Medicine at the ICPR Conference in the Netherlands, April 2020.
  2. There is a possibility for MDMA to have a non-responder effect. No one has done research dedicated to why some people don't react at all to MDMA.
  3. Psychedelic science is very hard to talk about. We have the language of science that studies the psychopharmacological effects of drugs but no language that holds the effects of an altered state of consciousness yet.

Support the show

Navigating Psychedelics


Show Notes

About Alicia

  • Her path to her current place is such a random road that led her to where she is
  • She was going to burning man and getting into harm reduction when she realized the untapped value of psychedelics, its where her interest began
  • She began volunteering, doing administrative work for a doctor
    • She was offered to be a study coordinator
  • She got introduced to the power of psilocybin as a medicine, for dying cancer patients
    • The patients had a prognosis from 6 months to a year
    • To see how this state of consciousness helped people transition to the end of life so smoothly, that is what inspired her
  • 5 months after she started working on the study, she got a cancer diagnosis

Getting Involved in the Space

  • Alicia would always get people approaching her about how to get in the field and she tells them “what field?”
  • Her Power Point making skills, are what technically got her involved in this field
  • “You never know what skill may be needed in this field” - Alicia
  • Alicia encourages people to look into their own collection of skills, and dig deep into that, find your niche, and then use that to contribute to the movement
    • Clinical therapists and psychologists are not the only people in this field
      We need accountants, marketers, etc

Consent

  • People start to get really religious around this field
  • Joe mentions a story where someone performed non-consensual reiki

Current Research

  • She is currently looking at why psychedelics appeal to people who typically like to abuse power
  • She did a talk at burning man about ‘coming down from the psychedelic power trip’
  • She tries to cite as many references and research as possible
  • Her talk at ICPR is going to be the very professional, version of that talk
  • Why are individuals who seek to abuse these tools so irresistibly drawn to psychedelics?
  • “If someone gets abused, and people say don't come out about it because it's not good for the movement, then what kind of movement is that?” - Joe

Empathogens

  • MDMA is known as an Empathogen
  • Can empathogens help people who are not empathetic, become empathetic?
  • Cohen’s D is the measure of effect size
    • Big pharma uses this all the time, to determine the effects of one drug compared to another
    • The Cohen’s D is how large that difference is

Non-response MDMA

  • There is a known, non-responder effect with MDMA
  • There was a few double-blind sessions, where the patient received MDMA, and they didn't react, their vitals didn't change
    • At the end,  it was revealed that they truly received MDMA, and then even to be sure, they would do a blood test, and it showed up in the blood
  • No one has done research dedicated to why some people don't react at all to MDMA
  • It's probably common, that for people who are relying on MDMA to work as their last resort option and try it and not feel anything at all, to end their life afterward

Media and Support

  • It's the most difficult thing in dealing with the media
    • When you are entirely dependent on funding, if you don't talk about what you're doing, then you can't get funding at all
  • There is a crisis in science on the replicability on these studies
    • Joe says its cool to have these studies replicated outside of the US
  • Psychedelic science is very hard to talk about due to the subjective nature of the psychedelic experience. We have the language of science that studies the psychopharmacological effects of drugs. There is no language that holds the effects of an altered state of consciousness yet.” - Alicia
  • The rapport that the patient and facilitator have, and the effect of that relationship, is a variable

Links

Website


About Alicia Danforth

Alicia received her doctorate in clinical psychology from the Institute of Transpersonal Psychology in Palo Alto in 2013. Since 2006, she has worked in clinical research at the Los Angeles Biomedical Research Institute at the Harbor-UCLA Medical Center on clinical studies for adults with anxiety related to advanced-stage cancer and with autistic adults who experience social anxiety. She is currently a lead clinician and supervisor for a clinical trial at UCSF for psychological distress in long-term survivors of HIV/AIDS. She is also certified in Trauma-Focused CBT and Focusing-Oriented Psychotherapy.  

Designed to help the body with cellular energy and cardiovascular endurance.

Get a 30 day free audible trial at audibletrial.com/psychedelicstoday